Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2012
08/23/2012US20120211736 Compound for organic photoelectric device and organic photoelectric device including the same
08/23/2012DE102010048476A1 Hybridverbindungen aus 4- und 8-Aminochinolinen zur prophylaktischen und therapeutischen Behandlung von Malaria und anderen parasitären Erkrankungen Hybrids consisting of 4- and 8-aminoquinolines for prophylactic and therapeutic treatment of malaria and other parasitic diseases
08/23/2012CA2827724A1 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
08/23/2012CA2827172A1 Selective fak inhibitors
08/23/2012CA2827171A1 Fak inhibitors
08/23/2012CA2826648A1 Aminoindane compounds and use thereof in treating pain
08/23/2012CA2826463A1 Novel sulfonaminoquinoline hepcidin antagonists
08/22/2012EP2489663A1 Compounds as syk kinase inhibitors
08/22/2012EP2488513A2 2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system
08/22/2012EP2488512A1 Cgrp receptor antagonists
08/22/2012EP2488511A1 Pyrazole inhibitors of phosphatidylinositol 3-kinase
08/22/2012EP2488510A1 Amides and thioamides as pesticides
08/22/2012EP2488503A1 Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon
08/22/2012EP2488496A1 Aminopropenoates as fungicides
08/22/2012EP2488493A1 Spiro-condensed cyclohexane derivatives as hsl inhibitors useful for the treatment of diabetes
08/22/2012EP2488491A1 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions
08/22/2012EP2488031A1 Diaryl ether derivatives as notch sparing gamma secretase inhibitors
08/22/2012EP2488030A1 1- (pyrid-3-yl) -pyrazole and 1- (pyrimid-5-yl) -pyrazole as pesticide
08/22/2012EP2488028A1 SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF
08/22/2012EP2181095B1 Novel bronchodilating alpha, beta-unsaturated isoquinoline amides
08/22/2012EP2057145B1 Synthesis of (2s,5r)-5-ethynyl-1-{n-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile
08/22/2012EP2046775B1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
08/22/2012EP2044056B1 Pyrimidine derivatives as alk-5 inhibitors
08/22/2012EP2041117B1 Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity
08/22/2012EP1976836B1 Nitrogen-containing bicyclic heteroaryl compounds for the treatment of raf protein kinase-mediated diseases
08/22/2012EP1924567B1 Process for the preparation of pyrimidinedione derivatives
08/22/2012EP1907374B1 Benzylpiperazine derivatives useful for the treatment of gastrointestinal disorders
08/22/2012EP1820798B1 7-membered ring compound, process for producing the same, and medicinal use thereof
08/22/2012EP1740581B1 2, 4, 6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
08/22/2012EP1401829B1 Novel heterocyclic antibacterial compounds
08/22/2012CN102648193A Spirocyclic compounds as modulators of chemokine receptor activity
08/22/2012CN102648177A New histone deacetylase inhibitors based simultaneously on trisubstituted 1H-pyrroles and aromatic and heteroaromatic spacers
08/22/2012CN102643654A Liquid crystal photo-alignment material and application thereof
08/22/2012CN102643268A 喹啉类及噌啉类化合物及其应用 Quinoline compounds and cinnolinyl class and its application
08/22/2012CN102643267A Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds
08/22/2012CN102643266A New preparation method of Lenalidomide B crystal form
08/22/2012CN102351846B Novel omeprazole sodium compound and medicinal composition thereof
08/22/2012CN101723900B Cinnamide compound
08/22/2012CN101397293B Green nitration method based on ion liquid catalysis
08/22/2012CN101247877B Hindered cyclic polyamines and their salts for acid gas scrubbing process
08/21/2012US8247576 Pyrazole derivatives as protein kinase modulators
08/21/2012US8247571 Pyridinium and thiazolium conjugates including polyethylene glycols and methods of using the same
08/21/2012US8247570 Process for preparing 2-amino-5-cyanobenzoic acid derivatives
08/21/2012US8247569 Cyclohexane derivative and pharmaceutical use thereof
08/21/2012US8247568 Process for the preparation of pure rabeprazole
08/21/2012US8247567 Process for solvent removal from omeprazole salts
08/21/2012US8247566 Crystalline solvate of omeprazole sodium
08/21/2012US8247563 5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydro-1H-inden-1-one ; for therapy of Alzheimer's disease, myasthenia gravis, Huntingtons disease or glaucoma
08/21/2012US8247562 Benzamide derivatives useful as histone deacetylase inhibitors
08/21/2012US8247432 Tripeptidyl peptidase inhibitors
08/21/2012US8247431 Heterocyclic hydrazide compound and pesticidal use of the same
08/21/2012US8247424 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers
08/21/2012US8247420 Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents
08/21/2012US8247414 Pyridizinone derivatives and the use thereof as H3 inhibitors
08/21/2012US8247413 e.g. N-[2-(3-fluorophenyl)ethyl]-N'-isoquinolin-5-ylurea; opioid receptor inhibitor; analgesic, antiinflammatory agent; inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity
08/21/2012US8247404 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
08/21/2012US8247401 P2X3 receptor antagonists for treatment of pain
08/21/2012CA2698332C Pyrazole derivatives as soluble guanylate cyclase activators
08/21/2012CA2568754C Method and reagent for measuring nitroreductase enzyme activity
08/21/2012CA2552319C Hcv ns-3 serine protease inhibitors
08/21/2012CA2545427C Selective kinase inhibitors
08/21/2012CA2516370C A process of preparing imatinib and imatinib prepared thereby
08/21/2012CA2497351C Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
08/21/2012CA2479877C Substituted tetracycline compounds
08/21/2012CA2476828C 2-amino-4-bicyclylamino-6h-1,3,5-triazines, processes for their preparation and their use as herbicides and plant growth regulators
08/21/2012CA2469076C Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
08/21/2012CA2452769C Antiviral agent
08/16/2012WO2012109544A1 Novel 1-(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
08/16/2012WO2012109423A1 Method of inhibiting hamartoma tumor cells
08/16/2012WO2012108511A1 Pyrazole derivative and pest control agent
08/16/2012WO2012108490A1 Isoquinoline amide derivative
08/16/2012WO2012107475A1 Microbiocidal pyrazole derivatives
08/16/2012WO2012107465A1 Heterocyclic compounds as pi3 kinase inhibitors
08/16/2012WO2012107434A1 Insecticidal compounds
08/16/2012WO2012088266A3 Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
08/16/2012WO2012050918A8 Tricyclic fused ring inhibitors of hepatitis c
08/16/2012WO2011042389A3 Phenylpyri(mi)dinylazoles and their use as fungicides
08/16/2012US20120209006 Process for the preparation of (r,s)-nicotine
08/16/2012US20120209005 Fused heterocyclic compounds and thrombopoietin receptor activators
08/16/2012US20120209001 Piperazinyl-propyl-pyrazole derivatives as dopamine d4 receptor antagonists, and pharmaceutical compositions containing the same
08/16/2012US20120208997 Novel compound having heterocyclic ring
08/16/2012US20120208989 Fluorinated aromatic materials and their use in optoelectronics
08/16/2012US20120208988 Heterodimers of glutamic acid
08/16/2012US20120208852 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
08/16/2012US20120208850 Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
08/16/2012US20120208847 Diagnostic and Therapeutic Alkyl Piperidine/Piperazine Compounds and Process
08/16/2012US20120208844 Substituted piperidines that increase p53 activity and the uses thereof
08/16/2012US20120208840 Condensed Ring Pyridine Compounds As Subtype-Selective Modulators Of Sphingosine-1-Phosphate-2 (S1P2) Receptors
08/16/2012US20120208828 Azole Derivatives as WTN Pathway Inhibitors
08/16/2012US20120208827 Benzimidazoles as fatty acid synthase inhibitors
08/16/2012US20120208826 Heterocyclic amide compounds as protein kinase inhibitors
08/16/2012US20120208825 Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts
08/16/2012US20120208821 Alpha adrenergic receptor modulators
08/16/2012US20120208819 Heterocyclic compounds useful as pdk1 inhibitors
08/16/2012US20120208818 Compounds useful as antagonists of ccr2
08/16/2012US20120208817 Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors
08/16/2012US20120208816 Organic compounds
08/16/2012US20120208815 Pim kinase inhibitors and methods of their use
08/16/2012US20120208814 Thetrahydroquinolines Derivatives As Bromodomain Inhibitors
08/16/2012US20120208813 3-carbamoyl-2-pyridone derivatives
1 ... 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 ... 1080